INC Research

INC Research offer Clinical Research Monitor Credential

Monday, September 16, 2013 03:05 PM

CRO INC Research has implemented the Clinical Research Monitor Accreditation program, an internationally recognized standard for competence in clinical research monitoring offered through the International Academy of Clinical Research (IAoCR).  The new clinical credentialing program standardizes training of CRAs and establishes INC Research as the first accredited training center in the U.S.

More... »

Patricia Monteforte named president of Trio Clinical Resourcing

Wednesday, August 21, 2013 04:40 PM

Aptiv Solutions, a global biopharmaceutical and medical device development services company, has appointed Patricia Monteforte president of Trio Clinical Resourcing, an Aptiv Solutions subsidiary focused on clinical and regulatory staffing. Monteforte will leverage more than 25 years in the pharmaceutical industry and success leading CROs to assemble teams of clinical and regulatory professionals to deliver flexible resourcing solutions to meet the current and future challenges in the pharmaceutical and medical device industry.

More... »

INC Research opens two offices in Japan

Tuesday, July 30, 2013 01:49 PM

Raleigh, N.C.-based INC Research, a therapeutically focused global CRO, has established INC Research Japan KK, with the opening of locations in Osaka and the Shinagawa ward in Tokyo. The new operations provide INC Research’s global drug development customers access to an increasingly significant market and further expand its presence in the Asia-Pacific region.

More... »

INC Research attained four Medidata Clinical Cloud accreditations

Monday, June 24, 2013 03:29 PM

INC Research, a therapeutically focused global CRO, has attained four new accreditations in the Medidata Clinical Cloud. With accreditations in Medidata Designer, Medidata Grants Manager, Medidata CTMS and Medidata Rave Safety Gateway, INC Research is the first company to achieve all available accreditations in the Medidata platform.

More... »

Wierman appointed Theorem vice president of biopharmaceutical development

Monday, May 13, 2013 08:00 AM

Theorem Clinical Research, a King of Prussia, Penn.-based, mid-sized provider of comprehensive clinical research and development services, has appointed Connie Wierman as vice president of biopharmaceutical development. Wierman leads the company’s oncology therapeutic focus for the biopharmaceutical business unit.

More... »

SynteractHCR hires Bill Pierce and Richard Paul

Thursday, April 4, 2013 08:00 AM

SynteractHCR, a full-service CRO, has hired two new senior executives to support the company's growth on a global scale following its recent merger. SynteractHCR has appointed Bill Pierce as chief information officer and Richard Paul as chief medical officer and vice president medical/regulatory affairs.

More... »

INC Research appoints James Taylor as vice president of clinical development

Tuesday, March 19, 2013 08:00 AM

INC Research, a therapeutically focused global CRO, has appointed James Taylor as vice president of clinical development.

More... »

INC Research promotes Tierney to executive vice president, Asia/Pacific

Friday, March 1, 2013 02:47 PM

Therapeutically focused CRO INC Research has promoted Garth Tierney to executive vice president, Asia/Pacific, responsible for driving the strategic development and overall growth of Asia/Pacific clinical research operations. Tierney, who was INC Research’s regional general manager for Australia and Southeast Asia, co-founded Trident Clinical Research, an Australia-based CRO acquired by INC Research in 2011 after 14 years of operation.

More... »

Neurovance receives patent for EB-1020, initiates ADHD trial

Friday, February 22, 2013 01:59 PM

The United States Patent and Trademark Office (USPTO) has issued Neurovance, a Cambridge, Mass.-based company spun out of Euthymics Bioscience, a notice of allowance for a composition of matter patent for EB-1020, providing proprietary protection for EB-1020 through July 2026.

More... »

INC Research select goBalto to enhance clinical study startup solution

Monday, January 14, 2013 12:31 PM

INC Research, a therapeutically-focused CRO, has selected a global site activation solution from goBalto, a developer of new-generation web clinical research solutions. goBalto Tracker 2.0 is a secure, web-based platform that enables study teams to track and manage site activation activities in clinical trials.

More... »